Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates significantly. Looking ahead, ...

We recently published a list of These 10 Stocks Were Wednesday’s Worst Performers. In this article, we are going to take a ...

Teva Pharmaceutical (NYSE:TEVA) shares snapped six straight sessions of losses, as the stock closed 0.88% higher at $17.21 on Wednesday. The company lost over 20% in the preceding six sessions. TEVA ...

Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range ...

Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of Teva ...

In this article, we are going to take a look at where Teva Pharmaceutical Industries Limited (NYSE:TEVA) stands among Wednesday’s worst-performing stocks. The stock market declined on Wednesday ...

Teva Pharmaceutical Industries' Q4 2024 results ... is intended to treat up to 11 million patients in the US still dependent on single-dose albuterol for asthma with a dual agent beta-agonist ...

Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor. Teva Pharmaceutical Indus: Delving into ...

Over the years, the U.S. Department of Justice (DOJ) has taken a host of drugmakers to task over alleged kickback payments ...

Israeli generics giant Teva Pharmaceutical Industries today reported results for the year and the quarter ended December 31, ...

SaverOne 2014 Ltd. (Nasdaq: SVRE, TASE: SVRE), a leading innovator in transportation safety technology, today announced the award of a new contract with Teva Pharmaceutical Industries Ltd. (Teva), to ...

北京时间2025年01月31日02时31分，梯瓦制药（TEVA.us）股票出现异动，股价大幅下挫5.04%。截至发稿，该股报17.61美元/股，成交量2073.05万股， 换手率 1.83%，振幅5.23%。